Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00379665 · ClinicalTrials.gov registry record · Phase 2

Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy

A Phase 2 study, sponsored by Southwestern Regional Medical Center.

Completed
Registry status
Phase 2
Development phase
25
Enrollment target

NCT00379665 is a Phase 2 study that has completed, run by Southwestern Regional Medical Center. The registered enrollment target is 25 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00379665, a Phase 2 study, has completed, sponsored by Southwestern Regional Medical Center.

COMPLETED
Registry status
Phase 2
Development phase
25 participants
Enrollment target

Study Summary

This study is being conducted in order to determine if intratumoral chemotherapy will be helpful in the palliation of endobronchial tumors when used in conjunction with endobronchial brachytherapy.

Interventions

  • DRUG Cisplatin

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2005-10
Est. Completion 2012-09
Phase Phase 2

What the Registry Record Tells You About NCT00379665

The ClinicalTrials.gov registry entry for NCT00379665 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Southwestern Regional Medical Center, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Cisplatin is the first listed.

NCT00379665 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00379665 about?

NCT00379665 is a clinical study titled "Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy". This study is being conducted in order to determine if intratumoral chemotherapy will be helpful in the palliation of endobronchial tumors when used in conjunction with endobronchial brachytherapy.

What is the current status of trial NCT00379665?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2005-10. Estimated completion is 2012-09.

What interventions are being tested in trial NCT00379665?

The interventions under investigation include: Cisplatin (DRUG).

Who is sponsoring clinical trial NCT00379665?

This trial is sponsored by Southwestern Regional Medical Center, which has 7 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.